An Estimate of the Proportion of Symptoms Reported in Self-Administered Questionnaires That Are Captured as Adverse Drug Events in an Observational Database
- 1 October 2007
- journal article
- Published by Taylor & Francis in HIV Research & Clinical Practice
- Vol. 8 (5) , 311-319
Abstract
This study was conducted to determine how frequently self-reported symptoms are captured as adverse drug events (ADEs) during chart abstraction.We studied Ontario Cohort Study (OCS) participants attending the Toronto Hospital Immunodeficiency Clinic and compared OCS data on ADEs collected semi-annually through chart review and a self-administered questionnaire, completed on up to three occasions, which asked about the frequency, severity, and chronicity of symptoms including diarrhea, nausea, fatigue, and changes in body shape. Among 64 participants who completed the questionnaires, the median age was 42 years, the median time since HIV diagnosis was 9 years, 84% were male, 58% were men who had sex with men, 70% had viral load levels below 50 copies/mL, and the median CD4 was 422 cells/mm3. All patients were taking antiretroviral therapy.The median (interquartile range) number of symptoms per participant reported on the questionnaire at the first visit was 3 (1-5). The most common symptoms reported by patients were diarrhea (58%), headache (59%), difficulty sleeping (52%), dry skin (53%), and changes in body shape (52%). The median number of ADEs during the study period per participant in OCS was 1 (0-2). Of 345 symptoms identified on the questionnaire, 16% were reported as ADEs in the OCS.Although some symptoms were correctly not classified as ADEs as they were not related to antiretroviral medication, others may have been missed due to incomplete reporting to the physician, incomplete physician recording, or errors in chart extraction.Keywords
This publication has 9 references indexed in Scilit:
- Commentary: We still need observational studies of drugs—they just need to be betterInternational Journal of Epidemiology, 2006
- Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping Due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C CoinfectionAIDS Research and Human Retroviruses, 2005
- Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor--Containing TherapyClinical Infectious Diseases, 2004
- Effects of Coding Dictionary on Signal GenerationDrug Safety, 2002
- Clinical Importance of Provider-Reported HIV Symptoms Compared With Patient-ReportMedical Care, 2001
- National Estimates of HIV-Related Symptom Prevalence From the HIV Cost and Services Utilization StudyMedical Care, 2000
- Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Physicians' Recognition of the Symptoms Experienced by HIV PatientsJournal of Pain and Symptom Management, 1999
- Short communicationJournal of Clinical Epidemiology, 1998